ESCMID, the largest European society active in the field of infection and VALUE-Dx partner, has recently released a Policy Statement addressing the lack of availability of existing antibiotics, and what ESCMID can do to contribute to tackling this issue.
In particular, ESCMID plans to lead, in collaboration with relevant stakeholders, activities aiming at identifying the existing antibiotics (including for pediatric use) that are essential and should at all times be available in all countries in Europe and including them in ESCMID guidelines and EUCAST testing recommendation. To this end, a consensus paper listing the current unmet needs regarding the repositioning of existing antibiotics will also be developed.
Finally, ESCMID would be willing to bring its scientific expertise and network to contribute to ongoing or future work done on this topic, at European or international level.
For more information, you can read the Policy Statement here.